Ársreikningur fagfjárfestasjóðsins SRE fjármögnun 2 vegna ársins 2016
/
Date02 Feb 2017
Ársreikningur fagfjárfestasjóðsins SRE fjármögnun 2 vegna ársins 2016
Access to Cannabis Should Not Occur Prior to Age 21, according to a position statement by the Canadian Consortium for Early Intervention in Psychosis
/
Date02 Feb 2017
HAMILTON, Ontario, Feb. 02, 2017 (GLOBE NEWSWIRE) — In response to the recommendations of the Task Force on Marijuana Legalization and Regulation, the Canadian Consortium... Read More →
Sotherly Hotels Inc. Announces Dividend Tax Treatment
/
Date02 Feb 2017
WILLIAMSBURG, Va., Feb. 02, 2017 (GLOBE NEWSWIRE) — Sotherly Hotels Inc. (NASDAQ:SOHO) (the “Company”) today announced the estimated income tax classification of the Company’s 2016... Read More →
Ársreikningur fagfjárfestasjóðsins SRE fjármögnun 1 vegna ársins 2016
/
Date02 Feb 2017
Ársreikningur fagfjárfestasjóðsins SRE fjármögnun 1 vegna ársins 2016
New Recommendations for Preventing Peanut Allergy
/
Date02 Feb 2017
ATLANTA, Feb. 02, 2017 (GLOBE NEWSWIRE) — As a way of preventing a life threatening peanut allergy, the National Institute of Allergy and Infectious Diseases... Read More →
Oval Partners Makes Strategic Investment in Cannon IV, Inc.
/
Date02 Feb 2017
Phoenix, Feb. 02, 2017 (GLOBE NEWSWIRE) — Oval Partners, a private equity firm based in San Francisco, announced today the investment in Cannon IV, Inc. ... Read More →
Nicholas Financial Reports 3rd Quarter Results
/
Date02 Feb 2017
CLEARWATER, Fla., Feb. 02, 2017 (GLOBE NEWSWIRE) — Nicholas Financial, Inc. (NASDAQ:NICK) announced that for the three months ended December 31, 2016, diluted earnings per... Read More →
CDK Global Reports Second Quarter Results and Updates FY 2017 Outlook; Provides Return of Capital and Leverage Targets through Calendar Year 2019
/
Date02 Feb 2017
HOFFMAN ESTATES, Ill., Feb. 02, 2017 (GLOBE NEWSWIRE) — CDK Global, Inc. (Nasdaq:CDK) today announced its second quarter fiscal 2017 financial results, updated its earnings... Read More →
Immune Therapeutics Clears Critical Certification Milestone
/
Date02 Feb 2017
Immune Therapeutics Receives Approval for Lodonal™ from theDominican Republic’s Ministry of Health and Social Assistance ORLANDO, Fla., Feb. 02, 2017 (GLOBE NEWSWIRE) — Immune Therapeutics,... Read More →
Parker Reports Fiscal 2017 Second Quarter Results
/
Date02 Feb 2017
Second quarter EPS increased 34% to $1.78, or $1.91 adjusted Fiscal 2017 second quarter includes $0.21 per share gain associated with the sale of a... Read More →